Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.ajo.2013.05.012
Title: Descemet stripping automated endothelial keratoplasty with a donor insertion device: Clinical results and complications in 100 eyes
Authors: Khor, W.-B.
Han, S.-B.
Mehta, J.S. 
Tan, D.T.H.
Issue Date: Oct-2013
Citation: Khor, W.-B., Han, S.-B., Mehta, J.S., Tan, D.T.H. (2013-10). Descemet stripping automated endothelial keratoplasty with a donor insertion device: Clinical results and complications in 100 eyes. American Journal of Ophthalmology 156 (4) : 773-779.e2. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ajo.2013.05.012
Abstract: Purpose: To study the clinical outcomes of Descemet stripping automated endothelial keratoplasty (DSAEK) with the EndoGlide donor insertion device. Design: Retrospective interventional case series. Methods: We included 100 eyes that underwent DSAEK for Fuchs endothelial dystrophy or pseudophakic bullous keratopathy (PBK) at a single institution. Eyes with anterior segment pathology or previous intraocular surgery (except for uncomplicated cataract surgery) were excluded. Preoperative data included visual acuity and donor endothelial cell density by specular microscopy. The main outcome measures were postoperative best spectacle-corrected visual acuity (BSCVA) and endothelial cell loss at 3, 6, and 12 months. Results: There were 59 eyes with Fuchs dystrophy and 41 eyes with PBK. In eyes without vision-limiting pathology, the median postoperative BSCVA was consistently 20/40 (range 20/20-20/400) at 3 months (n = 61 eyes), 6 months (n = 55 eyes), and 12 months (n = 48 eyes). Endothelial cell loss was 13.7% at 3 months (n = 57), 13.5% at 6 months (n = 61), and 14.9% at 12 months (n = 53). Primary graft failure occurred in 1 eye, attributable to incorrect use of the insertion device. Two eyes with complete donor dislocation were rebubbled successfully. The most common complication was glaucoma/ocular hypertension in 29 eyes (34.1%) without prior glaucoma and treatment escalation in 6 eyes (40.0%) with prior glaucoma. Of the 78 eyes with 12 months follow-up, 2 (2.6%) developed endothelial rejection, and 1 (1.3%) subsequently failed. Conclusions: The use of this donor insertion device during DSAEK demonstrates good outcomes and potentially low endothelial cell loss at up to 12 months after surgery.
Source Title: American Journal of Ophthalmology
URI: http://scholarbank.nus.edu.sg/handle/10635/110015
ISSN: 00029394
DOI: 10.1016/j.ajo.2013.05.012
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

25
checked on Oct 15, 2018

WEB OF SCIENCETM
Citations

21
checked on Oct 8, 2018

Page view(s)

47
checked on Jul 27, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.